Idera Pharmaceuticals to Host Conference Call and Webcast to Report First Quarter 2014 Financial Results and Provide a Detailed Pipeline Review

[Business Wire] – Idera Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel therapeutics for orphan patient populations with B-cell lymphomas and autoimmune diseases, today announced that the Company will host a conference more

View todays social media effects on IDRA

View the latest stocks trending across Twitter. Click to view dashboard

See who Idera is hiring next, click here to view